Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Dogwood Therapeutics, Inc (DWTX) vs Impact Biomedical Inc. (IBO)

Dogwood Therapeutics, Inc and Impact Biomedical Inc. are both Biotechnology companies. Dogwood Therapeutics, Inc and Impact Biomedical Inc. are of similar size ($48.6M and $48.3M). Dogwood Therapeutics, Inc has negative trailing earnings, so its P/E is not meaningful; Impact Biomedical Inc. trades at 6.5×. Impact Biomedical Inc. has the higher net margin (2,254.3% vs 0.00%) and the higher return on invested capital (−22.8% vs −41.2%). Across the 12 metrics below, Impact Biomedical Inc. leads on 8 and Dogwood Therapeutics, Inc on 4.

Valuation

Metric DWTX IBO Biotechnology median
P/E n/m 6.45 7.88
P/S n/m 17,528.61 11.47
P/B 0.68 43.78 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 17,756.07 10.73
Earnings yield (658.09%) 15.50% (28.84%)
Free cash flow yield (32.55%) (0.09%) (23.03%)

Profitability

Metric DWTX IBO Biotechnology median
Gross margin — (1,111.43%) 65.16%
Operating margin 0.00% (14,600.00%) 0.00%
Net margin 0.00% 2,254.29% 0.00%
Free cash flow margin 0.00% (1,451.43%) 0.00%
Return on equity (143.45%) 24.01% (57.72%)
Return on assets (40.68%) 4.41% (49.22%)
Return on invested capital (41.22%) (22.81%) 0.00%

Growth

Metric DWTX IBO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 43.05% 83.48% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DWTX IBO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.89 0.16 4.73
Net debt to EBITDA 0.23 0.00 0.96

Dividend

Metric DWTX IBO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric DWTX IBO Biotechnology median
Market cap 48.61m 48.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack